Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- Quarterly Reports
Quarterly Reports
| Date | Form | Description | Docs | XBRL | Pages |
| 05/10/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
83 |
| 11/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
56 |
| 08/10/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
88 |
| 05/12/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
66 |
| 11/08/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
115 |
| 08/12/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
| 05/13/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
36 |
| 11/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/13/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
29 |
| 05/11/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
27 |
